Sensitivity and specificity of CRP as a parameter of atherosclerosis in patients with type II diabetes mellitus
Background: Type 2 diabetes mellitus (T2DM) is an inflammatory atherosclerotic condition with high prevalence of cardiovascular disease. Elevated C-reactive protein (CRP) predicts cardiovascular events in T2DM patients.
Objectives: Our work aimed to assess sensitivity and specificity of CRP in diagnosis and follow up of carotid atherosclerosis in T2DM patients (detected by measuring carotid intima-media thickness CIMT).
Design and setting: It is observational cross sectional study on T2DM patients from outpatient clinic of fayoum university hospital.
Subjects and methods: Hundred patients with T2DM were included; Group I: statin un-treated, Group II: statin treated, and fifty healthy control persons. Laboratory measurement of total cholesterol, LDL, HDL, and serum CRP levels and carotid duplex scanning were done.
Results: The patients had higher levels of CRP and CIMT than control. There was strong correlation between CIMT and CRP level among group I and II. LDL in diagnosis of atherosclerosis disease illustrated sensitivity (80%) and specificity (4%), while HDL sensitivity (96%) and specificity (36%). CRP showed higher sensitivity (98%) and higher specificity (72%).
Conclusion: CRP level was an important parameter of atherosclerosis with good sensitivity and specificity regardless the level of LDL and HDL.
Keywords: Carotid Intima Media Thickness, C Reactive Protein, Type 2 Diabetes Mellitus.
L Lundby-Christensen, P Almdal, B Carstensen,et al. Carotid intima-media thickness in individuals with and without type 2 diabetes: a reproducibility study. Cardiovascular Diabetology 2010, 9:40 http://dx.doi.org/10.1186/1475-2840-9-40.
ML Bots, MK Palmer, S Dogan, et al: Intensive lipid lowering may reduce progression of carotid atherosclerosis within 12 months of treatment: the METEOR study. J Intern Med 2009, 265(6):698-707. http://dx.doi.org/10.1111/j.1365-2796.2009.02073.x.
JR Crouse, JS Raichlen, WA Riley, et al. for the METEOR Study Group: Effect of Rosuvastatin on Progression of Carotid Intima-Media Thickness in Low-Risk Individuals with Subclinical Atherosclerosis: The METEOR Trial. JAMA: The Journal of the American Medical Association 2007, 297:1344-1353. http://dx.doi.org/10.1001/jama.297.12.1344.
A Kablak-Ziembicka, T Przewlocki, A Sokołowski,et al. Carotid intima-media thickness, hs-CRP and TNF-_ are independently associated with cardiovascular event risk in patients with atherosclerotic occlusive disease. Atherosclerosis 2011; 214: 185–190 http://dx.doi.org/10.1016/j.atherosclerosis.2010.10.017.
L Biasucci, G Biasillo and a Stefanelli. Inflammatory markers, cholesterol and statins: pathophysiological role and clinical importance. Clin Chem Lab Med 2010; 48 (12):1685–1691 http://dx.doi.org/10.1515/CCLM.2010.277.
MG Veller, C Fisher, AN Nicolaides, et al. Measurement for the ultrasonic intima-media complex thickness in normal subjects. J Vasc Surg 1993; 17:719–25 http://dx.doi.org/10.1016/0741-5214 (93)90116-4.
A Pfützner, E Standl, HJ Strotmann, et al. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clin Chem Lab Med. 2006; 44 (5):556-60. http://dx.doi.org/10.1515/CCLM.2006.108.
M Soinio, J Marniemi, M Laakso, et al. High sensitivity C-reactive protein and coronary disease mortality in patients with type 2 diabetes. Diabetes Care 2006; 29: 329-33 http://dx.doi.org/10.2337/diacare.29.02.06.dc05-1700.
PM Ridker, JE Buring, NR Cook, and N Rifai. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003; 107 (3):391-7. http://dx.doi.org/10.1161/01.CIR.0000055014.62083.05.
S Devaraj, U Singh, I Jialal. Human C-reactive protein and the metabolic syndrome. Curr Opin Lipidol. 2009; 20(3):182-9. http://dx.doi.org/10.1097/MOL.0b013e32832ac03e.
N Kotb, R Gaber, M Salama, et al. Clinical and biochemical predictors of increased carotid intima-media thickness in overweight and obese adolescents with type 2 diabetes, Diabetes & Vascular Disease Research 2011.
M Naghavi, E falk, HS Hecht, ET al.SHAPE Task Force. From vulnerable Plaque to vulnerable patient –part III: Executive summary of the screening for heart Attack prevention and Education (SHAPE) task force report. Am J cardiol 2006; 98(2A) 2H-15H http://dx.doi.org/10.1016/j.amjcard.2006.03.002.
M Xu, Y Bi, Y Chen, et al. Increased C- reactive protein Associates with elevated carotid intima -media thickness in chinese adult with normal Low Density lipoprotein cholesterol. Journal of atherosclerosis and thrombosis 2013; 20.
S Tsimikas, J Willerson and P Ridker. C - reactive protein and Other Emerging Blood Biomarkers to Optimize Risk Stratification of Vulnerable Patients. Journal of the American College of Cardiology 2006 Vol. 47, No. 8 Suppl C 19- 31 http://dx.doi.org/10.1016/j.jacc.2005.10.066.
J Cao, C Thach, T Manolio, et al. C - reactive protein, Carotid Intima-Media Thickness, and Incidence of Ischemic Stroke in the Elderly The Cardiovascular Health Study. Circulation 2003. 108:166-170.) http://dx.doi.org/10.1161/01.CIR.0000079160.07364.6A.
S Kaul, RP Morrissey and GA Diamond. Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease – a perspective. Arch Intern Med 2010; 170:1073–77 http://dx.doi.org/10.1001/archinternmed.2010.189.
VM Patil, S Chaitanyakumar and V Patil. Diabetic nephropathy and its relation to inflammation. International Journal of Pharmacy and Biological Sciences 2013; 3, 117-127.
C Stehouwer, M Gall, J Twisk, et al. Increased urinary albumin excretion, endothelial dysfunction and chronic low grade inflammation in type 2 diabetes: progressive, interrelated and independently associated with risk of death. Diabetes 2002; 51: 1157-1165 http://dx.doi.org/10.2337/diabetes.51.4.1157.
LicenseAuthors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution Licensethat allows others to share the work with an acknowledgement of the work''s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal''s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open Access).